Loading...
XSAU
4004
Market cap2.29bUSD
Aug 31, Last price  
85.00SAR
Name

Dallah Healthcare Company SJSC

Chart & performance

D1W1MN
XSAU:4004 chart
P/E
15.99
P/S
2.12
EPS
5.32
Div yield, %
4.71%
Shrs. gr., 5y
3.28%
Rev. gr., 5y
25.27%
Revenues
4.07b
+26.87%
527,343,715637,058,049749,653,235895,103,764985,441,1971,162,788,9871,212,076,3151,180,942,0511,252,088,6771,318,253,9952,105,179,1072,487,983,1352,942,897,7013,205,734,0004,067,000,000
Net income
538m
+14.18%
113,401,424133,359,957136,632,897147,114,745165,057,068225,832,401294,976,212141,758,455146,915,95297,127,177258,601,120274,463,823360,122,537471,202,000538,000,000
CFO
386m
-43.11%
128,040,565125,010,944106,903,532149,436,728214,313,937341,570,910353,070,125204,680,012307,126,808183,301,268361,549,012442,131,337625,783,845678,287,000385,869,607
Dividend
Aug 10, 20260.5 SAR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Operating within the Kingdom of Saudi Arabia, Dallah Healthcare Company specializes in delivering and managing a comprehensive array of healthcare services and infrastructure. Its core activities encompass the operation, management, outfitting, and growth of hospitals, various medical establishments, polyclinics, residential healthcare complexes, and associated land. Additionally, it supplies essential personnel and ancillary services to both hospitals and medical centers. Beyond direct healthcare provision, Dallah Healthcare is also involved in the production and supply of pharmaceutical, herbal, and cosmetic goods, distributing them to individual pharmacies, health and beauty retailers, hospitals, and government bodies. The firm further extends its expertise to include the oversight and running of hospitals belonging to external entities, alongside offering various supplementary support functions. This encompasses the administration of private hospitals, specialized medical and diagnostic centers, and an analytical laboratory, coupled with the direct provision of medical care. Originally established as Dallah Healthcare Holding Company, the organization officially adopted its current name, Dallah Healthcare Company, in November 2016. Founded in 1994, its corporate headquarters are situated in Riyadh, Saudi Arabia, and it operates as a subsidiary of Dallah Al-Barakah Holding.

Key people

Tarek Othman Alkasabi
Non-Executive Chairman of the Board · since 2019
Ahmad Babaeer
Chief Executive Officer · since 2016
Non-Executive Vice Chairman of the Board · since 2022
Amin Bin Abdul Raouf Hariz
Chief Financial Officer · since 2024
Abdulaziz Saleh Al-wahaibi
Chief Operating Officer · since 2022
Ismail Abdullah
Chief Digital Transformation Officer · since 2024
Salah Rashid Al-Faqih
Chief Medical Officer · since 2023
Omar Mohammed Aljabari
Chief Commercial Officer- Dallah Health · since 2023
Muteab Abdullah Altukeas
Chief Strategy Officer - Dallah Health · since 2023
Mohammed Rashid Al-Faqih
Non-Executive Non-Independent Member of the Board · since 2023
Fahad Abdullah Al-Qassim
Non-Executive Non-Independent Member of the Board · since 2019
Non-Executive Non-Independent Member of the Board · since 2022
A. Amr Bin Mohammed Kamel
Non-Executive Non-Independent Member of the Board · since 2019
Khaled Mohammed Al Solai
Non-Executive Independent Member of the Board · since 2023
A. Abdullah Bin Turki Al-Sudairy
Non-Executive Independent Member of the Board · since 2019
Talal Bin Ibrahim Bin Ali Almaiman
Non-Executive Independent Member of the Board · since 2022
IPO date
Dec 16, 2012
Employees
Domiciled in
SA
Incorporated in
SA

Valuation

Title
SAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT